Teleflex Incorporated (TFX) key performance indicators and operating metrics (13 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Pro Forma Adjusted Constant Currency Revenue Growth | 5.10 percent | FY2026-Q1 |
| Pro Forma Adjusted Revenue - Interventional | 204.70 | FY2026-Q1 |
| Pro Forma Adjusted Revenue - Surgical | 106.80 | FY2026-Q1 |
| Pro Forma Adjusted Revenue - Vascular | 236.80 | FY2026-Q1 |
| Net Revenue - EMEA | 234.2M | FY2025-Q3 |
| Net Revenues - Americas | 555.9M | FY2025-Q3 |
| Net Revenues - Asia | 122.9M | FY2025-Q3 |
| Net Revenue - Interventional Urology | 71.8M | FY2025-Q3 |
| Net Revenue - Surgical | 122.9M | FY2025-Q3 |
| Anesthesia Revenue | 101.4M | FY2025-Q3 |
| Net Revenue - Access Interventional | 266.4M | FY2025-Q3 |
| Net Revenue - Vascular | 191M | FY2025-Q3 |
| Revenue - Other | 79.1M | FY2025-Q3 |
Back to TFX overview · TFX earnings · TFX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.